Home |  English version |  Mappa |  Commenti |  Sondaggio |  Staff |  Contattaci Cerca nel sito  
Istituto di fisiologia clinica

Torna all'elenco Contributi in atti di convegno anno 2017

Contributo in atti di convegno

Tipo: Presentazione

Titolo: Biomarkers, genetics and epigenomics in pediatric VAD Patients

Anno di pubblicazione: 2017

Formato: Elettronico

Autori: Chiara Caselli 1, Letizia Pitto1, Rosetta Ragusa 2, Arianna Di Molfetta 3, Concetta Prontera 4, Milena Rizzo 1, Romina D'Aurizio 5, Manuela Cabiati 1, Silvia Del Ry 1, Aldo Clerico 2-4, Antonio Amodeo 3, Maria Giovanna Trivella 1.

Affiliazioni autori: CNR Istitute of Clinical Physiology, Laboratory of Cardiovascular Biochemistry, Pisa 1,Scuola Superiore Sant'Anna, Istitute of Life Sciences, Pisa 2, Department of Cardiothoracic surgery, Ospedale Bambino Gesù, Roma 3, Fondazione Toscana Gabriele Monasterio, Pisa 4, CNR Institute of Informatics and Telematics, Pisa 5.

Autori CNR:

  • MANUELA CABIATI
  • CHIARA CASELLI
  • ROMINA D'AURIZIO
  • SILVIA DEL RY
  • LETIZIA PITTO
  • MILENA RIZZO
  • MARIA GIOVANNA TRIVELLA

Lingua: inglese

Abstract: Objective: Ventricular assist device (VAD) utilization is increasing in children with heart failure (HF) unresponsive to medical therapy, allowing for bridge to transplantation. The use of circulating biomarkers is crucial for the management of adult patients with HF, but their role in pediatric setting is unknown. In this study we assessed the effects of VAD implant on plasma levels of inflammatory and cardiac biomarkers as well as of circulating micro RNAs (miRNAs) in pediatric patients with HF. Methods: Blood samples were collected from 12 HF pediatric patients [73.91±27.94 (mean±SD) months, 6 males, 19±3.8 LVEF%, Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profiles 1/2] before and at 4 hrs, 1, 3, 7, 14 and 30 days after VAD implant. Indications for support was idiopathic dilated (9 patients), non compaction (2 patients) and hypertrophic cardiomyopathy (1 patient). Inflammatory and cardiac biomarkers (Figure 1A) were measured in frozen plasma through the use of immunoassay tests. The circulating miRNAs were extracted from serum samples and miRNA profile was determined by NGS. and validated by real-time PCR. Results: Inflammatory and cardiac biomarker levels during time-course were reported in Figure 1A. Cytokines increased significantly up to 4 hrs after VAD implant, while cardiac biomarkers up to 1 day. Only NT-proBNP decreased significantly up to 1 month of VAD implant compared to pre-VAD values. After sequencing, a total of 169 miRNAs were detected in serum samples. Among them, 13 miRNAs were simultaneously modulated at 1 month after VAD implant compared to pre-VAD levels, i.e. 9 miRNAs decrease and 4 increase (Figure 1B). Real-time PCR validation confirmed a reduction for miR-409-3p and miR-432-5p. Finally, significant correlations with bio-humoral markers were observed for these miRNAs (Figure 1 C). Conclusions: VAD implant induced modifications in circulating levels of cytokine, cardiac biomarkers and miRNAs. NT-proBNP levels and miRNAs significantly decreased after 1 month compared to the values pre-VAD, suggesting the involvement of these biomarkers in molecular mechanisms triggered by VAD implant in children.

Lingua abstract: inglese

Stato della pubblicazione: Preprint

Parole chiave:

  • VAD
  • Heart Failure in Children
  • Biomarkers
  • miRNA

Congresso nome: THE 13th INTERNATIONAL CONFERENCE ON PEDIATRIC MECHANICAL CIRCULATORY SUPPORT SYSTEMS & PEDIATRIC CARDIOPULMONARY PERFUSION

Congresso luogo: Roma

Congresso data: 28-30/09/2017

Congresso rilevanza: Internazionale

Congresso relazione: Su invito

Strutture CNR:

 
Torna indietro Richiedi modifiche Invia per email Stampa
Home Il CNR  |  I servizi News |   Eventi | Istituti |  Focus